(Q41151363)

27 September 2017

1 reference

title

Use of stimulants in the medically ill. (English)

1 reference

27 September 2017

Masand PS

1

1 reference

27 September 2017

Tesar GE

series ordinal

2

1 reference

27 September 2017

publication date

1 September 1996

1 reference

Psychiatric Clinics of North America

27 September 2017

published in

1 reference

27 September 2017

volume

19

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

515-547

1 reference

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Chemical structure and sympathomimetic action of amines

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The suicide rate of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Psychiatric aspects of aphasia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Biosynthesis of brain 2-phenylethylamine: influence of decarboxylase inhibitors and D-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The effect of methylphenidate (Ritalin) on post-halothane muscular spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Pemoline-induced choreoathetosis and rhabdomyolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The Use of Methylphenidate for Cognitive Decline Associated with HIV Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Effects of methylphenidate on cardiovascular responses in attention deficit hyperactivity disordered adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The use of psychostimulants in general psychiatry. A reconsideration

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

A new agent for shortening recovery time in oral surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

d-Amphetamine in Elderly Patients Refractory to Rehabilitation Procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Enuresis: a new look at stimulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Postoperative effects of methylphenidate.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Mood disorder following cerebrovascular accident

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Amphetamines: A Dangerous Illusion

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Cognitive impairment due to AIDS-related complex and its response to psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Effects of Methylphenidate in HIV-Related Depression: A Comparative Trial with Desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Dextroamphetamine with Morphine for the Treatment of Postoperative Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The effect of methylphenidate (ritalin) on thiopental recovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Interactions of various drugs with amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Cocaine and other stimulants. Actions, abuse, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Magnesium pemoline: stimulant effects on performance of fatigued subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Medical Use of Psychostimulants: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Pemoline and liver function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Withdrawn, Apathetic Geriatric Patients Responsive to Methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Treatment of depression in the medically ill elderly with methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Use of psychostimulants in medically ill depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Nortriptyline treatment of post-stroke depression: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Methylphenidate treatment of poststroke depression in a patient with global aphasia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Psychostimulants in post-stroke depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Hypomania precipitated by psychostimulant use in depressed medically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Psychostimulants for secondary depression in medical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The cancer patient with pain: psychiatric complications and their management

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Psychological factors affecting neurological conditions. Depression and stroke, multiple sclerosis, Parkinson's disease, and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Depression in epilepsy. Significance and phenomenology

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Pemoline-induced chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Pemoline-associated hepatic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Psychostimulants for depression in hospitalized cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Antidepressants and heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

(+)-Amphetamine binding to rat hypothalamus: relation to anorexic potency for phenylethylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Psychostimulant treatment of geriatric depressive disorders secondary to medical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The outcome of antidepressant use in the medically ill

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Antidepressant therapy after stroke. A double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Disability Caused by Minor Head Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Post-stroke depressive disorders: a follow-up study of 103 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

A two year longitudinal study of mood disorders following stroke. Prevalence and duration at six months follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Exacerbation by dextroamphetamine of spasticity in a patient with motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Sequelae of concussion caused by minor head injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Pemoline-induced abnormal involuntary movements

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Anxiety and depression after mild head injury: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Heterogeneity of amphetamine response in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Mood and food. A psychopharmacological enquiry

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Chorea in long-term use of pemoline

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Long-term methylphenidate use in the medically ill patient with organic mood syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Beneficial Effects of Dextro‐Amphetamine in the Treatment of Vasodepressor Syncope

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Residual complaints of patients two years after severe head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

The return of memory and personal meaning. Treatment and theoretical considerations in a case of viral encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Psychostimulants in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970304-X

7 January 2021

10.1016/S0193-953X(05)70304-X

Identifiers

DOI

1 reference

27 September 2017

1 reference